Allergy Therapeutics plc (AGYTF)
Develops allergy vaccines and immunotherapies to treat pollen and food allergies.
$0.15+0.00%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+76.5%
The outlook
AGYTF is trading near its 52-week high and above both its 50- and 200-day moving averages, suggesting positive momentum in its recent price trend. The stock sits at the upper end of its annual range. Analyst coverage appears limited, so investor research may be needed to assess current valuations and outlooks.
What’s behind the score
Price trendAbove its 50- & 200-day averages
52-week range100% of the way from its 52-week low to high
Market cap
$949.9M
52-wk high
$0.15
52-wk low
$0.09
50-day avg
$0.13
200-day avg
$0.12
Trailing P/E
—